About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 662 record(s)
Req # A-2023-000976
The following previously disclosed access to information requests: A-2021-000224, A-2019-001639, A-2019-000979.Organization: Health Canada
October 2023
Req # A-2019-001309
Adverse Drug Reactions (ADRs) for Mezavant, Xiidra. Report numbers: E2B_02564603, E2B_02608172, E2B_02605382, E2B_ 02644403, E2B_ 02645247.Organization: Health Canada
October 2023
Req # A-2019-002076
Adverse Drug Reaction (ADR). Report number: E2B_02697540.Organization: Health Canada
October 2023
Req # A-2020-000305
Adverse Drug Reactions (ADRs). Report numbers: E2B_02333532, E2B_02413346, E2B_02281231, E2B_02638001, E2B_02671175, E2B_02682842,E2B_02740843, E2B_02778702, E2B_02786752.Organization: Health Canada
October 2023
Req # A-2020-000549
Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: E2B_02831793, E2B_02825695, E2B_02848902, E2B_02955574, 734688, E2B_02818493, E2B_02903607, E2B_02909180.Organization: Health Canada
October 2023
Req # A-2021-001718
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_04368872, E2B_03380105.Organization: Health Canada
October 2023
Req # A-2021-001726
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: 000957304, 000962869.Organization: Health Canada
October 2023
Req # A-2022-000189
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075758-82.Organization: Health Canada
October 2023
Req # A-2022-000194
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-117522-158.Organization: Health Canada
October 2023
Req # A-2022-001204
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110754-450.Organization: Health Canada
October 2023